Advances in the treatment of central serous chorioretinopathy

Central serous chorioretinopathy is a disease that is partly understood. Novel advancements have led to further understanding of the disease, and have identified choroidal dysfunction as the principal element in CSCR development. New imaging tools have aided in better monitoring disease response to...

Full description

Saved in:
Bibliographic Details
Published inSaudi journal of ophthalmology Vol. 29; no. 4; pp. 278 - 286
Main Author Abouammoh, Marwan A.
Format Journal Article
LanguageEnglish
Published Saudi Arabia Elsevier B.V 01.10.2015
Elsevier
Subjects
Central serous chorioretinopathy
Central serous retinopathy
Corticosteroids
CSCR
Photodynamic therapy
Review
Treatment
CSCR
Central serous retinopathy
Photodynamic therapy
Corticosteroids
Treatment
Central serous chorioretinopathy
Online AccessGet full text

Cover

More Information
Summary:Central serous chorioretinopathy is a disease that is partly understood. Novel advancements have led to further understanding of the disease, and have identified choroidal dysfunction as the principal element in CSCR development. New imaging tools have aided in better monitoring disease response to various treatment models. Enhanced depth imaging optical coherence tomography, in particular, has helped in observing choroidal thickness changes after various treatment models. To date, photodynamic therapy and focal laser remain the main stay of treatment. More understanding of disease pathophysiology in the future will help in determining the drug of choice and the best management option for such cases.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:1319-4534
DOI:10.1016/j.sjopt.2015.01.007